EUVIMEDEUVIMED entdecken
Open Access

Bicyclic Pyrrolidine Inhibitors of Toxoplasma gondii Phenylalanine t-RNA Synthetase with Antiparasitic Potency In Vitro and Brain Exposure

Chloe C Ence, Taher Uddin, Julien Borrel, Payal Mittal, Han Xie, Jochen Zoller iD, Amit Sharma iD, Eamon Comer, Stuart L Schreiber iD, Bruno Melillo iD, L David Sibley iD, Arnab K Chatterjee iD

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Chloe C Ence und 11 weiteren Autor:innen. Beteiligte Einrichtung: Calibr at Scripps Research, La Jolla, California 92037, United States. Hauptthemen laut MEDLINE: Toxoplasma, Pyrrolidines, Brain, Phenylalanine-tRNA Ligase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Science and Engineering Research Board, Division of Microbiology and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have shown that bicyclic azetidines are potent and selective inhibitors of apicomplexan phenylalanine tRNA synthetase (PheRS), leading to parasite growth inhibition in vitro and in vivo, including in models of Toxoplasma infection. Despite these useful properties, additional optimization is required for the development of efficacious treatments of toxoplasmosis from this inhibitor series, in particular, to achieve optimal exposure in the brain. Here, we describe a series of PheRS inhibitors built on a new bicyclic pyrrolidine core scaffold designed to retain the exit-vector geometry of the isomeric bicyclic azetidine core scaffold while offering avenues to sample diverse chemical space. Relative to the parent series, bicyclic pyrrolidines retain reasonable potency and target selectivity for parasite PheRS vs host. Further structure-activity relationship studies revealed that the introduction of aliphatic groups improved potency and ADME and PK properties, including brain exposure. The identification of this new scaffold provides potential opportunities to extend the analogue series to further improve selectivity and potency and ultimately deliver a novel, efficacious treatment of toxoplasmosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmaPyrrolidinesBrainPhenylalanine-tRNA LigaseAnimalsStructure-Activity RelationshipAntiparasitic AgentsEnzyme InhibitorsMiceToxoplasmosisHumansAzetidines

Stichwörter der Autor:innen

anti-infectivecentral nervous system infectionsmall molecule inhibitortoxoplasmosis

Substanzen

PyrrolidinesPhenylalanine-tRNA LigaseAntiparasitic AgentsEnzyme InhibitorsAzetidines

Autor:innen und Institutionen

  • Calibr at Scripps Research, La Jolla, California 92037, United States.
  • Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63130, United States.
  • Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, Massachusetts 02142, United States.
  • Molecular Medicine-Structural Parasitology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi 110067, India.
  • ICMR-NIMR, Sector-8, Dwarka, New Delhi 110077, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

ORCID-Profile: Jochen Zoller, Amit Sharma, Stuart L Schreiber, Bruno Melillo, L David Sibley, Arnab K Chatterjee

Förderung

  • NIAID NIH HHS
  • Science and Engineering Research Board
  • Division of Microbiology and Infectious Diseases

Zitieren

APA

Ence, C. C., Uddin, T., Borrel, J., Mittal, P., Xie, H., Zoller, J., Sharma, A., Comer, E., Schreiber, S. L., Melillo, B., Sibley, L. D., & Chatterjee, A. K. (2024). Bicyclic Pyrrolidine Inhibitors of Toxoplasma gondii Phenylalanine t-RNA Synthetase with Antiparasitic Potency In Vitro and Brain Exposure. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00170

Vancouver

Ence CC, Uddin T, Borrel J, Mittal P, Xie H, Zoller J, et al. Bicyclic Pyrrolidine Inhibitors of Toxoplasma gondii Phenylalanine t-RNA Synthetase with Antiparasitic Potency In Vitro and Brain Exposure. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00170

BibTeX
@article{Ence2024,
  author = {Ence, Chloe C and Uddin, Taher and Borrel, Julien and Mittal, Payal and Xie, Han and Zoller, Jochen and Sharma, Amit and Comer, Eamon and Schreiber, Stuart L and Melillo, Bruno and Sibley, L David and Chatterjee, Arnab K},
  title = {Bicyclic Pyrrolidine Inhibitors of Toxoplasma gondii Phenylalanine t-RNA Synthetase with Antiparasitic Potency In Vitro and Brain Exposure},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00170}
}
Kostenlos starten →